Regeneron Pharmaceuticals’ Lynozyfic (linvoseltamab-gcpt) has been granted accelerated approval by the US Food and Drug ...

Alzheimer’s disease has rightly been characterised as a ‘silent pandemic’, with the number of Americans over 65 who are ...

Implementing AI in regulated industries like healthcare requires more than advanced technology. It demands strategic ...